ESC 365 - Usefulness of 2-year iodine-123 metaiodobenzylguanidine-based risk model for the post-discharge risk stratification in patients with acute decompensated heart failure

ESC Premium Access

Usefulness of 2-year iodine-123 metaiodobenzylguanidine-based risk model for the post-discharge risk stratification in patients with acute decompensated heart failure

Session: Poster Session 1 - Rare cases of heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr S. Tamaki (Ehime, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr Shunsuke Tamaki

Ehime University, Ehime (Japan)

0 follower

9 more presentations in this session

Iron status indices (transferrin saturation, serum ferritin) in the course of acute myocarditis: relations with neurohormonal activation, cardiac dysfunction and clinical recovery

Speaker: Mr P. Franczuk (Wroclaw, PL)

The impact of levothyroxine on cardiac function in older adults with subclinical hypothyroidism: a randomized clinical trial

Speaker: Doctor B. Gencer (Lausanne, CH)

The hemodynamic and prognostic effects of thyroid dysfunction types in heart failure: two sides of the blade

Speaker: Associate Professor M. Cetin (Ankara, TR)

Methamphetamine-associated cardiomyopathy: a case-controlled study of clinical characteristics, management and outcomes

Speaker: Doctor T. Wang (Cleveland, US)

Zika myocarditis prior diabetes bring out the worst

Speaker: Doctor K. Gonzalez Carta (Rochester, US)

Access the full session

Poster Session 1 - Rare cases of heart failure

Speakers: Mr S. Tamaki, Mr P. Franczuk, Doctor B. Gencer, Associate Professor M. Cetin, Doctor T. Wang...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources